Sinopharm Group Co Ltd

Return on Assets, %

3.7

2.4

Net income margin, %

2.7

1.5

EBITDA margin, %

4.7

4.6

Debt to Equity, %

98.9

35.4

Intangible assets and goodwill, %

2.6

1.8

Revenue CAGR 3Y, %

9.3

8.3

Revenue Y, % chg

2.4

1.5

P/E

6.1

17.4

P/BV

0.7

1.2

P/S

0

0.6

EV/S

0.1

0.8

EV/EBITDA

4.2

8.6

Average Analyst recommendation

Buy

Buy

Average upside forecasts, %

-71.4

20.7

Forward P/E

5.5

13.1

Dividend Yield, %

4.5

2.7

Forward Dividend Yield, %

1.1

0.5

Expected dividend per share

0.1

0.1

Payout Ratio, %

12

30.7

Dividend Ex Date

2023-06-15